Dublin, May 21, 2018 (GLOBE NEWSWIRE) -- The "Heart Pump Device Market by Product (Ventricular Assist Device (LVAD, RVAD, BiVAD, and pVAD), Intra Aortic Balloon Pump, TAH), Type (Extracorporeal and Implantable Pump), Therapy (Bridge-to-transplant, Destination Therapy) - Global Forecast to 2022" report has been added to ResearchAndMarkets.com's offering. The Global Heart Pump Devices Market is Projected to Reach USD 3.98 Billion By 2022 From an Estimated USD 1.64 Billion in 2017, at a CAGR Of 19.4% The report analyzes the heart pump devices market and aims at estimating the market size and future growth potential of this market based on various segments such as product, type, therapy, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies.
Rising prevalence of cardiovascular diseases, increasing number of regulatory approvals, and a huge gap between the demand and supply of donor hearts is driving the demand for heart pump devices. However, preference for alternative drug delivery modes and poor reimbursement scenario in developing countries is expected to restrain the growth of this market during the forecast period. Based on product, the market is segmented into ventricular assist devices, intra-aortic balloon pumps, and total artificial heart. The ventricular assist devices market is expected to grow at highest CAGR during the forecast period. This can be attributed to improved safety and efficacy of these devices as a result of technological advancements. Based on therapy, the global heart pump devices market is segmented into bridge-to-transplant, bridge-to-candidacy, destination therapy, and other therapies such as bridge-to-recovery and rescue therapy. The destination therapy segment is expected to grow at the highest CAGR during the forecast period. North America is expected to witness the highest growth during 2017 to 2022. The highest growth rate of the North American market is attributed to rising prevalence of cardiovascular diseases, favorable reimbursement scenario, and increasing regulatory approvals in that region.
Key Topics Covered:
1 Introduction 2 Research Methodology
3 Executive Summary 4 Premium Insights 4.1 Heart Pump Device Market Overview 4.2 Heart Pump Devices Market, By Product, 2017 vs 2022 4.3 Ventricular Assist Devices Market, By Vad Type, 2017 vs 2022 4.4 Heart Pump Device Market, By Type, 2017 vs 2022 4.5 Geographic Analysis: Heart Pump Device Market, By Therapy 4.6 Geographic Snapshot: Heart Pump Device Market 5 Market Overview 5.1 Introduction 5.2 Market Dynamics 5.2.1 Drivers 5.2.1.1 Rising Prevalence of Cardiovascular Diseases 5.2.1.2 Regulatory Approval of Several New and Advanced Heart Pump Devices 5.2.1.3 Huge Gap Between the Demand and Supply of Donor Hearts 5.2.2 Restraints 5.2.2.1 High Cost of Heart Pump Devices as Well as Implantation Procedures 5.2.3 Opportunities 5.2.3.1 Growth Potential Offered By Emerging Countries 5.2.4 Challenges 5.2.4.1 Limited Reimbursement for Heart Pump Devices for Destination Therapy 6 Heart Pump Devices Market, By Product 6.1 Introduction 6.1.1 Ventricular Assist Devices 6.1.1.1 Left Ventricular Assist Devices 6.1.1.2 Right Ventricular Assist Devices 6.1.1.3 Bi-Ventricular Assist Devices 6.1.1.4 Percutaneous Ventricular Assist Devices 6.1.2 Intra-Aortic Balloon Pumps 6.1.3 Total Artificial Heart 7 Heart Pump Devices Market, By Type 7.1 Introduction 7.1.1 Implantable Heart Pump Devices 7.1.2 Extracorporeal Heart Pump Devices 8 Heart Pump Devices Market, By Therapy 8.1 Introduction 8.1.1 Bridge-To-Candidacy (BTC) 8.1.2 Bridge-To-Transplant (BTT) 8.1.3 Destination Therapy (DT) 8.1.4 Other Therapies 9 Heart Pump Devices Market, By Region 9.1 Introduction 9.2 North America 9.2.1 US 9.2.2 Canada 9.3 Europe 9.3.1 EU5 9.3.2 Rest of Europe 9.4 Asia Pacific 9.4.1 Japan 9.4.2 China 9.4.3 India 9.4.4 Rest of Asia Pacific 9.5 Rest of the World 10 Competitive Landscape 10.1 Overview 10.2 Market Share Analysis 10.2.1 St. Jude Medical (Subsidiary of Abbott Laboratories) 10.2.2 Abiomed 10.2.3 Medtronic 10.3 Competitive Scenario 10.3.1 Product Launches and Approvals 10.3.2 Expansions 10.3.3 Agreements, Collaborations, and Partnerships 10.3.4 Acquisitions 11 Company Profiles 11.1 Abbott Laboratories 11.2 Abiomed 11.3 Medtronic 11.4 Getinge 11.5 Syncardia Systems 11.6 Teleflex 11.7 Reliantheart 11.8 Terumo 11.9 Berlin Heart 11.10 Jarvik Heart 11.11 Cardiacassist 11.12 Fresenius Medical Care
For more information about this report visit https://www.researchandmarkets.com/research/6..._pump?w=12
CONTACT: ResearchAndMarkets.com Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: Cardiovascular Devices
